Browse by Nurse Practitioner Items
Nurse practitioner PBS prescribing
MEDICINES WHICH MAY BE PRESCRIBED BY AUTHORISED NURSE PRACTITIONERS
From 1 September 2010, nurse practitioners endorsed to prescribe under state or territory legislation can apply for approval as PBS prescribers (authorised nurse practitioners). Information for nurse practitioners to become authorised PBS prescribers is available from Services Australia.
The medicines listed for prescribing by authorised nurse practitioners from 1 November 2010 are identified by ‘NP’ in the PBS Schedule. Nurse practitioners must not write PBS prescriptions for other medicines.
PBS prescribing is limited by a nurse practitioner’s scope of practice, and state and territory prescribing rights. Prescribing of PBS medicines is also contingent on a prescriber being an authorised nurse practitioner and having collaborative arrangements in place, as required by amendments to the National Health Act 1953.
The Pharmaceutical Benefits Advisory Committee (PBAC) is responsible for making recommendations to the Minister for Health regarding medicines for prescribing by authorised nurse practitioners.
Further to prescribing within collaborative arrangements, certain medicines also have additional conditions for prescribing by nurse practitioners, as recommended by the PBAC. These medicines are identified by the codes ‘CTO’ for continuation therapy only or ‘SCM’ for prescribing within a shared care model, as outlined below:
- Continuing therapy only model
Where the patient’s treatment and prescribing of a medicine has been initiated by a medical practitioner, but prescribing is continued by a nurse practitioner. (This is similar to existing arrangements between specialists and medical practitioners for prescribing certain medicines.)
- Shared care model
Where care is shared between a nurse practitioner and medical practitioner in a formalised arrangement with an agreed plan to manage the patient, in a patientcentred model of care. The details surrounding shared care arrangements will depend on the practitioners involved, patient needs and the healthcare context.
Some medicines are included in more than one section of the Schedule, and for more than one prescriber type. For a prescription to be eligible for subsidy, prescribers must ensure that they prescribe under the PBS only those medicines, and in accordance with the restrictions, listed for their prescriber type. Listing details for the same product may differ between sections and different PBS item codes apply for each prescriber type.
Nurse practitioner PBS prescriptions are identifiable by colour, and include the indicator ‘NP’ on personalised forms and a tick box on non-personalised (blank) forms.
Prescriptions must include the nurse practitioner’s PBS prescriber number. For unrestricted and restricted PBS medicines, midwives/nurse practitioners can use the personalised or non-personalised PBS prescriber forms. For authority required and authority required (streamlined) PBS medicines, midwives/nurse practitioners can use the authority personalised or non-personalised PBS prescriber forms. Nurse practitioner PBS prescriptions may include repeats.
Regulation 49 applies for nurse practitioner prescribing. A nurse practitioner can direct that original and repeat supplies of pharmaceutical benefits be supplied at the one time, if certain conditions are satisfied.
Authority prescriptions: Authority prescriptions for authority required items, or for increased quantities or repeats, require prior approval from Services Australia for each prescription. (Refer to Prescribing Medicines — Information for PBS prescribers and Supplying medicines — What Pharmacists Need to Know, for more information on authority prescriptions.)
State and territory requirements: Nurse practitioners may prescribe medicines as private prescriptions according to their state/territory prescribing accreditation. The medicines which can be prescribed differ between states and territories. It is the nurse practitioner’s responsibility to ensure adherence to State/Territory law for all prescriptions (PBS and private) and additionally to all PBS requirements for PBS prescriptions.
- Legend
- PPalliative care items
- MPMedical Practitioner
- MWMidwife
- NPNurse Practitioner
- OPOptometrist
-
SO
Products that are in a Supply Only state will be available for dispensing, but not for prescribing. PBS Prescriptions written prior to the Supply Only period are able to be dispensed using either the Supply Only product where available, or an equivalent product as specified on the PBS schedule.
Prescriber code | Item code | Name, manner of administration and form & strength | Max qty packs |
Max qty units |
No. of repeats |
---|---|---|---|---|---|
MPNP | 8393R | CABERGOLINEcabergoline 1 mg tablet, 30 | 1 | 30 | 5 |
MPNP | 8394T | CABERGOLINEcabergoline 2 mg tablet, 30 | 1 | 30 | 5 |
MPNP | 8115D | CABERGOLINEcabergoline 500 microgram tablet, 2 | 1 | 2 | 0 |
MPNP | 12939B | CABOTEGRAVIRcabotegravir 30 mg tablet, 30 | 1 | 30 | 0 |
MPNP | 12937X | CABOTEGRAVIR (&) RILPIVIRINEcabotegravir 600 mg/3 mL modified release injection [3 mL vial] (&) rilpivirine 900 mg/3 mL modified release injection [3 mL vial], 1 pack | 1 | 1 | 5 |
MPNP | 13577N | CALCIPOTRIOL + BETAMETHASONE DIPROPIONATEcalcipotriol 0.005% + betamethasone (as dipropionate) 0.05% ointment, 30 g | 2 | 2 | 1 |
MPNP | 9494Q | CALCIPOTRIOL + BETAMETHASONE DIPROPIONATEcalcipotriol 0.005% + betamethasone (as dipropionate) 0.05% ointment, 30 g | 1 | 1 | 1 |
MPNP | 11091R | CALCIPOTRIOL + BETAMETHASONE DIPROPIONATEcalcipotriol 0.005% + betamethasone (as dipropionate) 0.05% foam, 60 g | 1 | 1 | 1 |
MPNP | 13520N | CALCIPOTRIOL + BETAMETHASONE DIPROPIONATEcalcipotriol 0.005% + betamethasone (as dipropionate) 0.05% foam, 60 g | 2 | 2 | 1 |
MPNP | 2997R | CALCITONIN SALMONcalcitonin salmon 100 units/mL injection, 5 x 1 mL ampoules | 3 | 15 | 5 |
MPNP | 13457G | CALCITRIOLcalcitriol 0.25 microgram capsule, 100 | 2 | 200 | 3 |
MPNP | 2502Q | CALCITRIOLcalcitriol 0.25 microgram capsule, 100 | 1 | 100 | 3 |
MPNP | 13547B | CALCIUMcalcium carbonate 1.5 g (calcium 600 mg) tablet, 240 | 2 | 480 | 1 |
MPNP | 3117C | CALCIUMcalcium carbonate 1.5 g (calcium 600 mg) tablet, 240 | 1 | 240 | 1 |
MPNP | 11726E | CALCIUMcalcium carbonate 1.25 g (calcium 500 mg) chewable tablet, 120 | 2 | 240 | 1 |
MPNP | 13485R | CALCIUMcalcium carbonate 1.25 g (calcium 500 mg) chewable tablet, 120 | 4 | 480 | 1 |
MPNP | 13565Y | CANDESARTANcandesartan cilexetil 16 mg tablet, 30 | 2 | 60 | 5 |
MPNP | 8297Q | CANDESARTANcandesartan cilexetil 16 mg tablet, 30 | 1 | 30 | 5 |
MPNP | 13438G | CANDESARTANcandesartan cilexetil 32 mg tablet, 30 | 2 | 60 | 5 |
MPNP | 8889W | CANDESARTANcandesartan cilexetil 32 mg tablet, 30 | 1 | 30 | 5 |
MPNP | 13592J | CANDESARTANcandesartan cilexetil 4 mg tablet, 30 | 2 | 60 | 5 |
MPNP | 8295N | CANDESARTANcandesartan cilexetil 4 mg tablet, 30 | 1 | 30 | 5 |
MPNP | 13436E | CANDESARTANcandesartan cilexetil 8 mg tablet, 30 | 2 | 60 | 5 |
MPNP | 8296P | CANDESARTANcandesartan cilexetil 8 mg tablet, 30 | 1 | 30 | 5 |
MPNP | 13391T | CANDESARTAN + HYDROCHLOROTHIAZIDEcandesartan cilexetil 16 mg + hydrochlorothiazide 12.5 mg tablet, 30 | 2 | 60 | 5 |
MPNP | 8504N | CANDESARTAN + HYDROCHLOROTHIAZIDEcandesartan cilexetil 16 mg + hydrochlorothiazide 12.5 mg tablet, 30 | 1 | 30 | 5 |
MPNP | 13452B | CANDESARTAN + HYDROCHLOROTHIAZIDEcandesartan cilexetil 32 mg + hydrochlorothiazide 12.5 mg tablet, 30 | 2 | 60 | 5 |
MPNP | 9314F | CANDESARTAN + HYDROCHLOROTHIAZIDEcandesartan cilexetil 32 mg + hydrochlorothiazide 12.5 mg tablet, 30 | 1 | 30 | 5 |
MPNP | 13392W | CANDESARTAN + HYDROCHLOROTHIAZIDEcandesartan cilexetil 32 mg + hydrochlorothiazide 25 mg tablet, 30 | 2 | 60 | 5 |
MPNP | 9315G | CANDESARTAN + HYDROCHLOROTHIAZIDEcandesartan cilexetil 32 mg + hydrochlorothiazide 25 mg tablet, 30 | 1 | 30 | 5 |
MPNP | 8760C | CAPTOPRILcaptopril 5 mg/mL oral liquid, 95 mL | 1 | 1 | 5 |
MPNP | 14051M | CARBAMAZEPINEcarbamazepine 100 mg/5 mL oral liquid, 300 mL | 2 | 2 | 5 |
MPNP | 2427R | CARBAMAZEPINEcarbamazepine 100 mg/5 mL oral liquid, 300 mL | 1 | 1 | 5 |
MPNP | 2422L | CARBAMAZEPINEcarbamazepine 100 mg tablet, 100 | 2 | 200 | 2 |
MPNP | 1706T | CARBAMAZEPINEcarbamazepine 200 mg tablet, 100 | 2 | 200 | 2 |
MPNP | 14050L | CARBAMAZEPINEcarbamazepine 200 mg modified release tablet, 200 | 2 | 400 | 2 |
MPNP | 2426Q | CARBAMAZEPINEcarbamazepine 200 mg modified release tablet, 200 | 1 | 200 | 2 |
MPNP | 13918M | CARBAMAZEPINEcarbamazepine 400 mg modified release tablet, 200 | 2 | 400 | 2 |
MPNP | 2431Y | CARBAMAZEPINEcarbamazepine 400 mg modified release tablet, 200 | 1 | 200 | 2 |
MPNP | 1153Q | CARBIMAZOLEcarbimazole 5 mg tablet, 100 | 2 | 200 | 2 |
MPNP | 13967D | CARBIMAZOLEcarbimazole 5 mg tablet, 100 | 4 | 400 | 2 |
MPNP | 8369L | CARBOHYDRATE, FAT, VITAMINS, MINERALS AND TRACE ELEMENTScarbohydrate, fat, vitamins, minerals and trace elements powder for oral liquid, 400 g | 8 | 8 | 5 |
MPNP | 10039J | CARBOHYDRATES, FAT, VITAMINS, MINERALS, TRACE ELEMENTS AND SUPPLEMENTED WITH ARACHIDONIC ACID AND DOCOSAHEXAENOIC ACIDcarbohydrates, fat, vitamins, minerals, trace elements and supplemented with arachidonic acid and docosahexaenoic acid providing 200 kilocalories powder for oral liquid, 30 x 43 g sachets | 4 | 4 | 5 |
MPNP | 8514D | CARBOMER-974Pcarbomer-974P 0.3% eye gel, 30 x 500 mg ampoules | 3 | 3 | 5 |
MPNP | 8384G | CARBOMER-980carbomer-980 0.2% eye gel, 10 g | 1 | 1 | 5 |
MPNP | 8578L | CARBOMER-980carbomer-980 0.2% eye drops, 30 x 600 mg ampoules | 3 | 3 | 5 |
MPNP | 12652X | CARIPRAZINEcariprazine 1.5 mg capsule, 30 | 1 | 30 | 5 |
MPNP | 12619E | CARIPRAZINEcariprazine 3 mg capsule, 30 | 1 | 30 | 5 |
MPNP | 12653Y | CARIPRAZINEcariprazine 4.5 mg capsule, 30 | 1 | 30 | 5 |
MPNP | 12622H | CARIPRAZINEcariprazine 6 mg capsule, 30 | 1 | 30 | 5 |
MPNP | 8593G | CARMELLOSE SODIUMcarmellose sodium 1% eye drops, 15 mL | 1 | 1 | 5 |
MPNP | 2324H | CARMELLOSE SODIUMcarmellose sodium 1% eye drops, 30 x 0.4 mL ampoules | 3 | 3 | 5 |
MPNP | 8548X | CARMELLOSE SODIUMcarmellose sodium 0.5% eye drops, 15 mL | 1 | 1 | 5 |
MPNP | 2338C | CARMELLOSE SODIUMcarmellose sodium 0.5% eye drops, 30 x 0.4 mL ampoules | 3 | 3 | 5 |
MPNP | 11852T | CARMELLOSE SODIUMcarmellose sodium 0.5% eye drops, 10 mL | 1 | 1 | 5 |
MPNP | 9355J | CARMELLOSE SODIUM + GLYCEROLcarmellose sodium 0.5% + glycerol 0.9% eye drops, 15 mL | 1 | 1 | 3 |
MPNP | 13418F | CARVEDILOLcarvedilol 12.5 mg tablet, 60 | 2 | 120 | 5 |
MPNP | 8257N | CARVEDILOLcarvedilol 12.5 mg tablet, 60 | 1 | 60 | 5 |
MPNP | 13387N | CARVEDILOLcarvedilol 25 mg tablet, 60 | 2 | 120 | 5 |
MPNP | 8258P | CARVEDILOLcarvedilol 25 mg tablet, 60 | 1 | 60 | 5 |
MPNP | 8255L | CARVEDILOLcarvedilol 3.125 mg tablet, 30 | 1 | 30 | 0 |
MPNP | 13417E | CARVEDILOLcarvedilol 6.25 mg tablet, 60 | 2 | 120 | 5 |
MPNP | 8256M | CARVEDILOLcarvedilol 6.25 mg tablet, 60 | 1 | 60 | 5 |
MPMWNP | 11963P | CEFALEXINcefalexin 250 mg capsule, 20 | 2 | 40 | 0 |
MPMWNP | 3058Y | CEFALEXINcefalexin 250 mg capsule, 20 | 1 | 20 | 0 |
MPMWNP | 11934D | CEFALEXINcefalexin 500 mg capsule, 20 | 2 | 40 | 0 |
MPMWNP | 3119E | CEFALEXINcefalexin 500 mg capsule, 20 | 1 | 20 | 0 |
MPNP | 3094W | CEFALEXINcefalexin 125 mg/5 mL powder for oral liquid, 100 mL | 1 | 1 | 1 |
MPNP | 3095X | CEFALEXINcefalexin 250 mg/5 mL powder for oral liquid, 100 mL | 1 | 1 | 1 |
MPNP | 1797N | CEFAZOLINcefazolin 1 g injection, 5 vials | 2 | 10 | 0 |
MPNP | 1799Q | CEFAZOLINcefazolin 1 g injection, 5 vials | 2 | 10 | 0 |
MPNP | 12115P | CEFAZOLINcefazolin 2 g injection, 10 vials | 1 | 10 | 0 |
MPNP | 12118T | CEFAZOLINcefazolin 2 g injection, 10 vials | 1 | 10 | 0 |
MPNP | 1256D | CEFAZOLINcefazolin 500 mg injection, 5 vials | 2 | 10 | 0 |
MPNP | 5477G | CEFAZOLINcefazolin 500 mg injection, 5 vials | 2 | 10 | 0 |
MPNP | 8315P | CEFEPIMEcefepime 1 g injection, 1 vial | 10 | 10 | 0 |
MPNP | 8316Q | CEFEPIMEcefepime 2 g injection, 1 vial | 10 | 10 | 0 |
MPNP | 1758M | CEFOTAXIMEcefotaxime 1 g injection, 10 vials | 1 | 10 | 0 |
MPNP | 1783W | CEFTRIAXONEceftriaxone 500 mg injection, 1 vial | 5 | 5 | 0 |
MPNP | 9058R | CEFTRIAXONEceftriaxone 500 mg injection, 1 vial | 1 | 1 | 0 |
MPNP | 12112L | CEFTRIAXONEceftriaxone 2 g injection, 10 vials | 0.5 | 5 | 0 |
MPNP | 12114N | CEFTRIAXONEceftriaxone 1 g injection, 10 vials | 0.5 | 5 | 0 |
MPNP | 1788D | CEFTRIAXONEceftriaxone 1 g injection, 5 vials | 1 | 5 | 0 |
MPNP | 11169W | CEFTRIAXONEceftriaxone 2 g injection, 5 vials | 1 | 5 | 0 |
MPNP | 8439E | CELECOXIBcelecoxib 100 mg capsule, 60 | 1 | 60 | 3 |
MPNP | 8440F | CELECOXIBcelecoxib 200 mg capsule, 30 | 1 | 30 | 3 |
MPMWNPOP | 11112W | CHLORAMPHENICOLchloramphenicol 0.5% eye drops, 10 mL | 1 | 1 | 2 |
MPNP | 1195X | CHLORPROMAZINEchlorpromazine hydrochloride 50 mg/2 mL injection, 10 x 2 mL ampoules | 1 | 10 | 0 |
MPNP | 3455W | CHLORPROMAZINEchlorpromazine hydrochloride 50 mg/2 mL injection, 10 x 2 mL ampoules | 1 | 10 | 0 |
MPNP | 1201F | CHLORPROMAZINEchlorpromazine hydrochloride 5 mg/mL oral liquid, 100 mL | 1 | 1 | 5 |
MPNP | 1199D | CHLORPROMAZINEchlorpromazine hydrochloride 100 mg tablet, 100 | 1 | 100 | 5 |
MPNP | 1197B | CHLORPROMAZINEchlorpromazine hydrochloride 25 mg tablet, 100 | 1 | 100 | 5 |
MPNP | 13500M | CHLORTALIDONEchlortalidone 25 mg tablet, 50 | 4 | 200 | 1 |
MPNP | 1585K | CHLORTALIDONEchlortalidone 25 mg tablet, 50 | 2 | 100 | 1 |
MPNP | 8854B | CICLESONIDEciclesonide 160 microgram/actuation inhalation, 120 actuations | 1 | 1 | 5 |
MPNP | 8853Y | CICLESONIDEciclesonide 80 microgram/actuation inhalation, 120 actuations | 1 | 1 | 5 |
MPNP | 9157Y | CINACALCETcinacalcet 30 mg tablet, 28 | 1 | 28 | 5 |
MPNP | 9158B | CINACALCETcinacalcet 60 mg tablet, 28 | 1 | 28 | 5 |
MPNP | 9159C | CINACALCETcinacalcet 90 mg tablet, 28 | 1 | 28 | 5 |
MPNP | 1210Q | CIPROFLOXACINciprofloxacin 750 mg tablet, 14 | 1 | 14 | 0 |
MPNP | 2480M | CIPROFLOXACINciprofloxacin 0.3% ear drops, 5 mL | 1 | 1 | 1 |
MPNP | 1208N | CIPROFLOXACINciprofloxacin 250 mg tablet, 14 | 1 | 14 | 0 |
MPNP | 1209P | CIPROFLOXACINciprofloxacin 500 mg tablet, 14 | 1 | 14 | 0 |
MPNP | 8702B | CITALOPRAMcitalopram 10 mg tablet, 28 | 1 | 28 | 5 |
MPNP | 8220P | CITALOPRAMcitalopram 20 mg tablet, 28 | 1 | 28 | 5 |
MPNP | 8703C | CITALOPRAMcitalopram 40 mg tablet, 28 | 1 | 28 | 5 |
MPNP | 2091C | CITRIC ACID + LAURYL SULFOACETATE SODIUM + SORBITOLsodium citrate dihydrate 450 mg/5 mL + lauryl sulfoacetate sodium 45 mg/5 mL + sorbitol 3.125 g/5 mL enema, 12 x 5 mL | 2 | 2 | 2 |
MPNP | 5331N | CITRIC ACID + LAURYL SULFOACETATE SODIUM + SORBITOLsodium citrate dihydrate 450 mg/5 mL + lauryl sulfoacetate sodium 45 mg/5 mL + sorbitol 3.125 g/5 mL enema, 12 x 5 mL | 2 | 2 | 3 |
MPNP | 10736C | CITRULLINEcitrulline 1 g tablet, 300 | 1 | 1 | 5 |
MPNP | 5481L | CITRULLINE WITH CARBOHYDRATEcitrulline with carbohydrate containing 1 g citrulline powder for oral liquid, 30 x 4 g sachets | 4 | 4 | 5 |
MPNP | 9192T | CLARITHROMYCINclarithromycin 250 mg/5 mL powder for oral liquid, 50 mL | 1 | 1 | 0 |
MPNP | 8318T | CLARITHROMYCINclarithromycin 250 mg tablet, 14 | 1 | 14 | 1 |
MPMWNP | 3138E | CLINDAMYCINclindamycin 150 mg capsule, 24 | 2 | 48 | 1 |
MPNP | 1561E | CLOMIPRAMINEclomipramine hydrochloride 25 mg tablet, 50 | 1 | 50 | 2 |
MPNP | 12534Q | CLONAZEPAMclonazepam 1 mg/mL injection [5 x 1 mL ampoules] (&) inert substance diluent [5 x 1 mL ampoules], 1 pack | 1 | 5 | 1 |
MPNP | 1807D | CLONAZEPAMclonazepam 1 mg/mL injection [5 x 1 mL ampoules] (&) inert substance diluent [5 x 1 mL ampoules], 1 pack | 1 | 5 | 0 |
MPNP | 1808E | CLONAZEPAMclonazepam 2.5 mg/mL (0.1 mg/drop) oral liquid, 10 mL | 2 | 2 | 0 |
MPNP | 3478C | CLONAZEPAMclonazepam 2.5 mg/mL (0.1 mg/drop) oral liquid, 10 mL | 1 | 1 | 0 |
MPNP | 5339B | CLONAZEPAMclonazepam 2.5 mg/mL (0.1 mg/drop) oral liquid, 10 mL | 2 | 2 | 3 |
MPNP | 1806C | CLONAZEPAMclonazepam 2 mg tablet, 100 | 2 | 200 | 2 |
MPNP | 5338Y | CLONAZEPAMclonazepam 2 mg tablet, 100 | 1 | 100 | 3 |
MPNP | 1805B | CLONAZEPAMclonazepam 500 microgram tablet, 100 | 2 | 200 | 2 |
MPNP | 5337X | CLONAZEPAMclonazepam 500 microgram tablet, 100 | 1 | 100 | 3 |
MPNP | 11520H | CLONAZEPAMclonazepam 500 microgram tablet, 50 | 2 | 100 | 3 |
MPNP | 11559J | CLONAZEPAMclonazepam 500 microgram tablet, 50 | 4 | 200 | 2 |
MPNP | 13578P | CLONIDINEclonidine hydrochloride 100 microgram tablet, 100 | 2 | 200 | 5 |
MPNP | 3145M | CLONIDINEclonidine hydrochloride 100 microgram tablet, 100 | 1 | 100 | 5 |
MPNP | 13548C | CLONIDINEclonidine hydrochloride 150 microgram tablet, 100 | 2 | 200 | 5 |
MPNP | 3141H | CLONIDINEclonidine hydrochloride 150 microgram tablet, 100 | 1 | 100 | 5 |
MPNP | 13365K | CLOPIDOGRELclopidogrel 75 mg tablet, 28 | 2 | 56 | 5 |
MPNP | 13399F | CLOPIDOGRELclopidogrel 75 mg tablet, 28 | 2 | 56 | 5 |
MPNP | 8358X | CLOPIDOGRELclopidogrel 75 mg tablet, 28 | 1 | 28 | 5 |
MPNP | 9354H | CLOPIDOGRELclopidogrel 75 mg tablet, 28 | 1 | 28 | 5 |
MPNP | 13427Q | CLOPIDOGREL + ASPIRINclopidogrel 75 mg + aspirin 100 mg tablet, 30 | 2 | 60 | 5 |
MPNP | 9296G | CLOPIDOGREL + ASPIRINclopidogrel 75 mg + aspirin 100 mg tablet, 30 | 1 | 30 | 5 |
MPNP | 12065B | CODEINEcodeine phosphate hemihydrate 30 mg tablet, 20 | 0.5 | 10 | 0 |
MPNP | 1214X | CODEINEcodeine phosphate hemihydrate 30 mg tablet, 20 | 1 | 20 | 0 |
MPNP | 3410L | COLCHICINEcolchicine 500 microgram tablet, 30 | 1 | 30 | 5 |
MPNP | 13351Q | COLESTYRAMINEcolestyramine 4 g powder for oral liquid, 30 sachets | 3.33 | 100 | 5 |
MPNP | 14132T | COLESTYRAMINEcolestyramine 4 g powder for oral liquid, 60 pouches | 2 | 120 | 5 |
MPNP | 2967E | COLESTYRAMINEcolestyramine 4 g powder for oral liquid, 50 sachets | 2 | 2 | 5 |
MPNP | 1247P | CORTISONEcortisone acetate 25 mg tablet, 60 | 1 | 60 | 4 |
MPNP | 13862N | CORTISONEcortisone acetate 25 mg tablet, 60 | 2 | 120 | 4 |
MPNP | 1246N | CORTISONEcortisone acetate 5 mg tablet, 50 | 1 | 50 | 4 |
MPNP | 13946B | CORTISONEcortisone acetate 5 mg tablet, 50 | 2 | 100 | 4 |